Related references
Note: Only part of the references are listed.Lupus erythematosus revisited
Annegret Kuhn et al.
SEMINARS IN IMMUNOPATHOLOGY (2016)
Fumaric acid esters in the management of psoriasis
Deepak M. W. Balak
PSORIASIS-TARGETS AND THERAPY (2015)
Successful treatment of discoid lupus erythematosus with fumaric acid esters
Athanasios Tsianakas et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
The Immunopathology of Cutaneous Lupus Erythematosus
Mark G. Kirchhof et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2014)
Cutaneous lupus erythematosus: First multicenter database analysis of 1002 patients from the European Society of Cutaneous Lupus Erythematosus (EUSCLE)
Cyrus Biazar et al.
AUTOIMMUNITY REVIEWS (2013)
Off-label use of fumarate therapy for granulomatous and inflammatory skin diseases other than psoriasis vulgaris: a retrospective study
A. Klein et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2012)
Treatment of lupus erythematosus with fumaric acid ester derivatives: two case-reports
Deepak MW Balak et al.
Journal of Translational Medicine (2011)
Treatment of severe, recalcitrant, chronic plaque psoriasis with fumaric acid esters: a prospective study
E. M. Wain et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Cutaneous lupus erythematosus: Update of therapeutic options
Annegret Kuhn et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2010)
15 Jahre Fumaderm®: FumarsAureester fur die systemische Behandlung der mittelschweren und schweren Psoriasis vulgaris
Ulrich Mrowietz et al.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2009)
Fumaric acid esters in severe psoriasis, including experience of use in combination with other systemic modalities
P Balasubramaniam et al.
BRITISH JOURNAL OF DERMATOLOGY (2004)
Share Paper
